Dr. Cappelli’s research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.
Abstract Link
Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg